Drugmakers Aim at Early Stage Cancer Patients With Immunotherapy – BloombergQuint

Drugmakers Aim at Early Stage Cancer Patients With Immunotherapy
BloombergQuint
(Bloomberg) — AstraZeneca Plc, Bristol-Myers Squibb Co. and other drugmakers are switching gears on standard drug development in an effort to quickly test powerful new therapies in earlier stages of cancer. Treatments are usually first tested

and more »

Source: Business and finance

Leave a Reply

Your email address will not be published. Required fields are marked *